Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancerM Boucaud, F Pinguet, S Poujol, et al.
Bulletin Du Cancer|January 1, 1987
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trialG Romieu, T Maudelonde, A Ulmann, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 26, 2004
[Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art]D Azria, C Lemanski, A Zouhair, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumorsS Culine, M Fabbro, C Assens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patientsN Kluger, W Jacot, E Frouin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2008
Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapyV Diéras, S Limentani, G Romieu, et al.
Critical Reviews in Oncology/Hematology|February 24, 2007
Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trialG Romieu, M Clemens, R Mahlberg, et al.
Targeted Oncology|April 24, 2013
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06C Villanueva, G Romieu, J Salvat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Trastuzumab duration effects within patient prognostic subgroups in the PHARE trialA Kramar, T Bachelot, N Madrange, et al.
British Journal of Cancer|August 26, 2004
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patientsD Azria, S Gourgou, W J Sozzi, et al.
Pageof 3